Studies on UK biosimilar medicines market

There are many reports and briefings on developments in the UK and European biosimilar markets. We have curated the following list of recommended reading for individuals or organisations looking to find out more about this part of the off-patent sector.

Reports on biosimilars

Medicines UK - Supporting a competitive medicines market

See the report

Iqvia - The Impact of Biosimilar Competition in Europe 2024

See the report

MHRA Guidance on the licensing of biosimilar products

See the report

NHS England - What is a biosimilar medicine?

See the report

Medicines of Europe - Biosimilars market review

See the report

Latest industry news

News

Partnership will revive inactive licences to solve critical medicines shortages

Project Revive is an innovative collaboration between NHS England, the MHRA and Medicines UK. The initiative will encourage manufacturers to relaunch dormant already MHRA approved licences through a dedicated regulatory pathway and NHS purchasing arrangements. A list of nearly 400 products has been identified by the NHS for the pilot programme, where the NHS considers them a resilience priority, or there is only one or no suppliers.

Posted on 5 Feb 2026
By Jeremy Durrant

Studies on UK biosimilar medicines market

Reports on biosimilars

Join today

Latest industry news

Partnership will revive inactive licences to solve critical medicines shortages

Find us on